Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Arcus Biosciences is a biopharmaceutical company that discovers, develops, and commercializes novel therapies for the treatment of cancer.
Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood disorders.
Alector is combining state-of-the-art antibody technology and recent discoveries in neuroimmunology and human genetics to develop novel.
Verastem is a biopharmaceutical company developing new medicines to improve the lives of patients with RAS/MAPK pathway-driven cancers.
Suki develops artificial intelligence solutions to assist clinicians with clinical documentation and administrative tasks.
Capitolis provides technology and financial solutions designed to improve capital efficiency and reduce risk across capital markets.
Bright Machines brings together flexible factory robots with intelligent software, production data and machine learning.
Locus Robotics is a warehouse robotics company that manufactures autonomous mobile robots to support e-commerce.
4D Molecular Therapeutics designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.
MoonLake Immunotherapeutics is a clinical-stage biopharmaceuticals company.
Behavox is an AI-driven platform that enables you to aggregate, analyze, and act on your entire organization’s data.
Eloxx Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel RNA-modulating drug candidates.
Funnel designs and develops software/platforms that help marketers automate their data collection for reporting and analysis.
Phathom Pharmaceuticals is a biopharmaceutical company.
Govini is a software company that transforms defense acquisition and national-security decision-making through data, analytics, and AI.
Snappt provides fraud detection and income verification software for multifamily property managers.
Madrigal Pharmaceuticals is a biopharmaceutical company developing therapeutics for the treatment of cardiovascular-metabolic diseases.
Axsome Therapeutics is a biopharmaceutical company that develops therapies for the management and treatment of neurological disorders.
Main Street Health is a supplier of value-based, care-focused healthcare services designed to address rural wellness challenges.
Genetix Biotherapeutics develops and delivers approved gene therapies for severe rare genetic diseases like sickle cell.
Remodel Health delivers software to assist employers in managing health benefits and transitioning to ICHRA.
Hypercore provides a cloud-based platform that manages loan portfolios from origination through repayment.
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
X4 Pharmaceuticals is a clinical-stage oncology company developing oral small molecule CXCR4 antagonists for the treatment.
Hercules Capital has invested in 73 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Hercules Capital's top investment sectors include Biotechnology, Health Care, Pharmaceutical, Software, Therapeutics. The firm invests across 41 different industry categories.
Among tracked funding rounds, Axsome Therapeutics received $570.0M in a Post-IPO Debt round. Hercules Capital's total known invested capital is $8.2B.
Hercules Capital's average investment size is $113.0M across its portfolio of 73 companies.
Recent Hercules Capital portfolio additions include Arcus Biosciences, Disc Medicine, Alector, Verastem Oncology, Suki. These companies were founded in 2020 or later.